Domenique D. Zomer-van Ommen

Long‐term expanding human airway organoids for disease modeling

Norman Sachs, Angelos Papaspyropoulos, Domenique D. Zomer-van Ommen et al. · The EMBO Journal · 2019 · 1K citations · Full text

Incidence of SARS-CoV-2 in people with cystic fibrosis in Europe between February and June 2020

Lutz Naehrlich, Annalisa Orenti, Fiona Dunlevy et al. · Journal of Cystic Fibrosis · 2021 · 57 citations · Full text

Pulmonary Pathology, Respiratory Diseases, Covid-19 Pandemic +6

Limited premature termination codon suppression by read-through agents in cystic fibrosis intestinal organoids

Domenique D. Zomer-van Ommen, L.A.W. Vijftigschild, Evelien Kruisselbrink et al. · Journal of Cystic Fibrosis · 2015 · 52 citations

Fibrosis, Read-through Agents, Gastrointestinal Pharmacology +4

Comparison of ex vivo and in vitro intestinal cystic fibrosis models to measure CFTR-dependent ion channel activity

Domenique D. Zomer-van Ommen, Eyleen de Poel, Evelien Kruisselbrink et al. · Journal of Cystic Fibrosis · 2018 · 52 citations

Fibrosis, Molecular Physiology, Medicine +9

Functional Characterization of Cholera Toxin Inhibitors Using Human Intestinal Organoids

Domenique D. Zomer-van Ommen, Aliaksei V. Pukin, Ou Fu et al. · Journal of Medicinal Chemistry · 2016 · 50 citations

Drug Analysis, Preclinical Drug Evaluation, Organoid-based Swelling Assay +15